甲状腺功能遗传预测因素与心房颤动的关联:全表型关联研究及逆方差加权平均荟萃分析
IMPORTANCE: Thyroid hormone levels are tightly regulated through feedback inhibition by thyrotropin, produced by the pituitary gland.…
要点
- 遗传预测的TSH每升高1个标准差,心房颤动风险降低(OR 0.86)。
- 在正常范围内的直接测量TSH水平与心房颤动风险呈负相关。
- 治疗亚临床甲状腺疾病时需权衡抗甲状腺药物或甲状腺激素替代对心房颤动风险的影响。
核心结论
- 遗传决定的甲状腺功能在生理正常范围内的变异可能是心房颤动的风险因素。
研究设计与样本
- 另在745例病例和1680例对照(年龄>55岁)中分析直接测量的TSH水平与心房颤动风险的关联。
主要发现
- TSH多基因预测因子与甲状腺功能减退正相关(OR 1.10,95%CI 1.07-1.14,P=5×10^-11),与甲状腺功能亢进相关诊断负相关(毒性多结节性甲状腺肿OR 0.64,95%CI 0.54-0.74,P=2×10^-8)。
- 排除9801名有甲状腺疾病诊断的个体后,心房颤动关联持续存在(OR 0.91,95%CI 0.88-0.95,P=2.9×10^-6)。
- 在重复荟萃分析中,遗传预测的TSH每升高1个标准差与心房颤动风险降低相关(OR 0.86,95%CI 0.79-0.93,P=4.7×10^-4)。
临床怎么用
- 治疗亚临床甲状腺疾病时,临床决策应纳入心房颤动风险:抗甲状腺药物可能降低心房颤动风险,而甲状腺激素替代可能增加心房颤动风险。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
IMPORTANCE: Thyroid hormone levels are tightly regulated through feedback inhibition by thyrotropin, produced by the pituitary gland. Hyperthyroidism is overwhelmingly due to thyroid disorders and is well recognized to contribute to a wide spectrum of cardiovascular morbidity, particularly the increasingly common arrhythmia atrial fibrillation (AF). OBJECTIVE: To determine the association between genetically determined thyrotropin levels and AF. DESIGN, SETTING, AND PARTICIPANTS: This phenome-wide association study scanned 1318 phenotypes associated with a polygenic predictor of thyrotropin levels identified by a previously published genome-wide association study that included participants of European ancestry. North American individuals of European ancestry with longitudinal electronic health records were analyzed from May 2008 to November 2016. Analysis began March 2018. MAIN OUTCOMES AND MEASURES: Clinical diagnoses associated with a polygenic predictor of thyrotropin levels. EXPOSURES: Genetically determined thyrotropin levels. RESULTS: Of 37 154 individuals, 19 330 (52%) were men. The thyrotropin polygenic predictor was positively associated with hypothyroidism (odds ratio [OR], 1.10; 95% CI, 1.07-1.14; P = 5 × 10-11) and inversely associated with diagnoses related to hyperthyroidism (OR, 0.64; 95% CI, 0.54-0.74; P = 2 × 10-8 for toxic multinodular goiter). Among nonthyroid associations, the top association was AF/flutter (OR, 0.93; 95% CI, 0.9-0.95; P = 9 × 10-7). When the analyses were repeated excluding 9801 individuals with any diagnoses of a thyroid-related disease, the AF association persisted (OR, 0.91; 95% CI, 0.88-0.95; P = 2.9 × 10-6). To replicate this association, we conducted an inverse-variance weighted average meta-analysis using AF single-nucleotide variant weights from a genome-wide association study of 17 931 AF cases and 115 142 controls. As in the discovery analyses, each SD increase in predicted thyrotropin was associated with a decreased risk of AF (OR, 0.86; 95% CI, 0.79-0.93; P = 4.7 × 10-4). In a set of AF cases (n = 745) and controls (n = 1680) older than 55 years, directly measured thyrotropin levels that fell within the normal range were inversely associated with AF risk (OR, 0.91; 95% CI, 0.83-0.99; P = .04). CONCLUSIONS AND RELEVANCE: This study suggests a role for genetically determined variation in thyroid function within a physiologically accepted normal range as a risk factor for AF. The clinical decision to treat subclinical thyroid disease should incorporate the risk for AF as antithyroid medications to treat hyperthyroidism may reduce AF risk and thyroid hormone replacement for hypothyroidism may increase AF risk.
引用
- Salem JE, Shoemaker MB, Bastarache L, et al. Association of Thyroid Function Genetic Predictors With Atrial Fibrillation: A Phenome-Wide Association Study and Inverse-Variance Weighted Average Meta-analysis. JAMA Cardiol. 2019. PMID: 30673079. doi:10.1001/jamacardio.2018.4615
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。